( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .



    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019


    NOVEMBER 2021 Issue has been successfully launched on 1 November 2021

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 November 2021 Issue has been Published, Kindly check it on

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here




Loujain Roumieh, Soha Asaad, Usama Alanan* and Zuheir Alshehabi


Background: Cancer is the second leading cause of. In many developing countries, the incidence of cancer appears to be much lower. Most patients are treated with a combination of surgery-radiology and/ Or chemotherapy, while in most cases the primary tumor is effectively treated with a combination of these standard treatments. Cancer immunotherapy is the use of the immune system to treat cancer. Immunotherapy is often divided into active, inactive or compound immunotherapy. This treatment highlights the fact that cancer cells often have slightly different molecules on their surface than normal cells that can be detected by the immune system. The aim of this research is to make a narrative revision on the topic of cancer immunotherapy from its beginnings to even its development with its various types and categories. Materials and Methods: Many articles and scientific researches dealing with the topic of cancer immunotherapy have been referenced. New ideas in those researches have been approached and the ideas that support the importance of immunotherapy have been arranged, as well as the challenges facing the application of this type of treatment in the treatment of cancer. Discussion: These immune cells can be reactivated and stimulated by inhibiting PD-1/PD-L1 resulting in the recognition and killing of cancer cells. However, not all cancers present appropriate immune antigens that can be effectively recognized by autologous T cells. Synthetic immune responses are the result of treatments that artificially link T cells to cancer cells that do not normally do so based on the T cell's binding to the histocompatibility complex. Conclusion: Immunotherapy is a long way of hope for the ability to treat different types of cancer, and this is still subject to continued researches in this field.

[Full Text Article]